[
  {
    "ts": null,
    "headline": "HCA Healthcare Positioned to Withstand Policy Shifts Through Resiliency Program, RBC Says",
    "summary": "HCA Healthcare (HCA) expects to mitigate a significant portion of headwinds from changing US healthc",
    "url": "https://finnhub.io/api/news?id=569fedb34252af6a6ca20f651c167e2cb26dc8044a00c5c504560815a9d0ae96",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750689150,
      "headline": "HCA Healthcare Positioned to Withstand Policy Shifts Through Resiliency Program, RBC Says",
      "id": 135482050,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HCA",
      "source": "Yahoo",
      "summary": "HCA Healthcare (HCA) expects to mitigate a significant portion of headwinds from changing US healthc",
      "url": "https://finnhub.io/api/news?id=569fedb34252af6a6ca20f651c167e2cb26dc8044a00c5c504560815a9d0ae96"
    }
  },
  {
    "ts": null,
    "headline": "IR-MED Reports Positive Interim Results from U.S. Clinical Study of PressureSafe(TM) for Pressure Injury Assessment Across Diverse Skin Tones",
    "summary": "PressureSafe™, IR-MED's lead product, demonstrated 94% sensitivity in assessing tissue at risk for pressure injuries prior to visible skin breakdownTechnology addresses longstanding disparities in skin assessment, particularly in patients with darker skin tonesResults presented at HCA Healthcare & Galen College of Nursing Research Day; additional data to be featured at a podium session at the 2025 ANCC Magnet/ANE Research SymposiumRosh Pina, Israel--(Newsfile Corp. - June 23, 2025) - As the U.S.",
    "url": "https://finnhub.io/api/news?id=d8464b798d2bdd29d7487963acf5c5296ed97fe455151015d7ae76d371401949",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750681800,
      "headline": "IR-MED Reports Positive Interim Results from U.S. Clinical Study of PressureSafe(TM) for Pressure Injury Assessment Across Diverse Skin Tones",
      "id": 135482051,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HCA",
      "source": "Yahoo",
      "summary": "PressureSafe™, IR-MED's lead product, demonstrated 94% sensitivity in assessing tissue at risk for pressure injuries prior to visible skin breakdownTechnology addresses longstanding disparities in skin assessment, particularly in patients with darker skin tonesResults presented at HCA Healthcare & Galen College of Nursing Research Day; additional data to be featured at a podium session at the 2025 ANCC Magnet/ANE Research SymposiumRosh Pina, Israel--(Newsfile Corp. - June 23, 2025) - As the U.S.",
      "url": "https://finnhub.io/api/news?id=d8464b798d2bdd29d7487963acf5c5296ed97fe455151015d7ae76d371401949"
    }
  },
  {
    "ts": null,
    "headline": "5 Insightful Analyst Questions From HCA Healthcare’s Q1 Earnings Call",
    "summary": "HCA Healthcare’s first quarter results reflected continued momentum in patient volumes and revenue growth, but the market responded negatively due to margin pressure and a slower pace of same-store sales expansion. Management noted that growth was driven by higher inpatient admissions, improved payer mix, and disciplined cost management, with CEO Sam Hazen highlighting progress in “broad-based volume growth, improved payer mix, and better operating margin.” However, CFO Mike Marks acknowledged t",
    "url": "https://finnhub.io/api/news?id=2e0d00880cc3ac88596f8cafd91eb2227514930ad5ab182ff551022bfe1074ff",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750649615,
      "headline": "5 Insightful Analyst Questions From HCA Healthcare’s Q1 Earnings Call",
      "id": 135482052,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HCA",
      "source": "Yahoo",
      "summary": "HCA Healthcare’s first quarter results reflected continued momentum in patient volumes and revenue growth, but the market responded negatively due to margin pressure and a slower pace of same-store sales expansion. Management noted that growth was driven by higher inpatient admissions, improved payer mix, and disciplined cost management, with CEO Sam Hazen highlighting progress in “broad-based volume growth, improved payer mix, and better operating margin.” However, CFO Mike Marks acknowledged t",
      "url": "https://finnhub.io/api/news?id=2e0d00880cc3ac88596f8cafd91eb2227514930ad5ab182ff551022bfe1074ff"
    }
  }
]